APPENDIX 1

Submissions and additional information received by the Committee

Submissions

1	Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine
2	Australasian Tuberculosis Forum
3	AusBiotech
4	Roche Products Pty Ltd
5	Melanoma Patients Australia
6	Pharmaceutical Society of Australia
7	IVD Australia
8	Medical Technology Association of Australia
9	Novartis
10	ACON
11	Complementary Medicines Australia
12	BIOTRONIK Australia Pty Ltd
13	Day Hospitals Australia
14	Pfizer Australia
15	Australian Federation of AIDS Organisations
16	Prostheses List Advisory Committee
17	Research Australia
18	Merck Sharp & Dohme
19	Haemophilia Foundation Australia
20	Australian Medical Device Manufacturers and Distributers
21	Medicines Australia
22	Department of Health
23	Swisse Wellness
24	Stryker
25	Rare Cancers Australia
26	Cancer Drugs Alliance
27	Consumers Health Forum of Australia
28	Medtronic Australasia Pty Ltd
29	Bristol-Myers Squibb Australia
30	Australian Self Medication Industry
31	Australian and New Zealand Society for Vascular Surgery
32	Health Consumers' Council WA
33	Australian Nuclear Science and Technology Organisation
34	Generic and Biosimilar Medicines Association Australia
35	Glaxo Smith Klein
36	Australian Traditional Medicine Society
37	Johnson & Johnson
38	Australian Dental Association
39	Confidential
40	Medical Oncology Group of Australia
41	Australian Taxpayers Alliance and MyChoice Australia (plus three attachments)
42	Cochlear Ltd
43	Royal Australasian College of Physicians (plus an attachment)
44	Australian Dental Industry Association

Answers to Questions on Notice

1	Answers to Questions taken on Notice during 17 March public hearing, received from Department of Health, 27 March 2017